Celltrion, Inc. (KRX:068270)
South Korea
· Delayed Price · Currency is KRW 183,300
+700 (0.38%)
At close: Dec 5, 2025
Revenue
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2015 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2015 - 2020 |
| Biopharmaceutical Medicines Revenue | 6,663.56B | 6,070.13B |
Log In |
Log In |
Log In | Upgrade
|
| Chemical Medicines Revenue | 517.00B | 531.39B |
Log In |
Log In |
Log In | Upgrade
|
| Other Segments Revenue | 7.24B | 5.82B |
Log In |
Log In |
Log In | Upgrade
|
| Adjustments to Revenue | -3,438.85B | -3,050.04B |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2015 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2015 - 2020 |
| Domestic Revenue | 1,480.68B | 1,554.99B |
Log In |
Log In |
Log In | Upgrade
|
| Americas Revenue | - | - |
Log In |
Log In |
Log In | Upgrade
|
| Asia Revenue | 211.23B | 192.46B |
Log In |
Log In |
Log In | Upgrade
|
| Europe Revenue | 1,654.44B | 1,500.81B |
Log In |
Log In |
Log In | Upgrade
|
| North America Revenue | 279.01B | 168.09B |
Log In |
Log In |
Log In | Upgrade
|
| Central and South America Revenue | 123.60B | 140.96B |
Log In |
Log In |
Log In | Upgrade
|
EBIT
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2015 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2015 - 2020 |
| Biopharmaceutical Medicines Operating Income | 1,473.68B | 1,199.11B |
Log In |
Log In |
Log In | Upgrade
|
| Chemical Medicines Operating Income | 14.11B | 9.18B |
Log In |
Log In |
Log In | Upgrade
|
| Other Segments Operating Income | 1.37B | 505.60M |
Log In |
Log In |
Log In | Upgrade
|
| Adjustments to Operating Income | -693.18B | -716.79B |
Log In |
Log In |
Log In | Upgrade
|